Scientists in the US say they have developed an mRNA-based vaccine that encompasses all 20 known subtypes of influenza that could form the basis of a future universal jab. While the shot is still ...

There is one approved therapy for CSU, Novartis injectable antibody Xolair (omalizumab), which got a green light for the condition in 2014, and there is a lot of interest in oral therapies that ...